Skip to main content

Articles

Perspectives
Compensation for Managing Population Health
Read More
Original Research
Longitudinal Commercial Claims–Based Cost Analysis of Diabetic Retinopathy Screening Patterns
Stakeholder Perspective
The Economics of Screening Patients with Diabetes for Diabetic Retinopathy
Read More
Practice Management
Evaluating Drug Cost per Response with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus
Stakeholder Perspective
Evaluating the Benefits and Cost of the Sodium-Glucose Cotransporter 2 Inhibitors
Read More
Practice Management
The Impact of HbA1c Testing on Total Annual Healthcare Expenditures Among Newly Diagnosed Patients with Diabetes
Stakeholder Perspective
Saving Money Is Not Always the Objective
Read More
FDA Approvals
Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Patients with Heart Failure
Read More
Perspectives
Ahead of the Curve
Read More
Perspectives
Guiding Employer Management of Specialty Drugs
Read More
Practice Management
Trends in Medicare Part D Medication Therapy Management Eligibility Criteria
Stakeholder Perspective
Is It Time to Revisit Medicare Part D?
Read More
Original Research
Value-Based Benefit Design to Improve Medication Adherence for Employees with Anxiety or Depression
Stakeholder Perspective
Counting on a Run of Value-Based Benefit Design
Read More
Practice Management
US Healthcare Annual Spending Estimated to Rise by 5.8% on Average Through 2024
Read More
Page 127 of 244
Results 1261 - 1270 of 2439